Rosiglitazone on Microalbuminuria in Type 2 Diabetics

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

June 30, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone

Trial Locations (113)

3400

GSK Investigational Site, Durango

10010

GSK Investigational Site, New York

12206

GSK Investigational Site, Albany

13760

GSK Investigational Site, Endwell

13903

GSK Investigational Site, Binghamton

14080

GSK Investigational Site, México

15221

GSK Investigational Site, Pittsburgh

15705

GSK Investigational Site, Santiago de Compostela

16148

GSK Investigational Site, Hermitage

18003

GSK Investigational Site, Granada

19124

GSK Investigational Site, Philadelphia

19713

GSK Investigational Site, Newark

21208

GSK Investigational Site, Baltimore

23249

GSK Investigational Site, Richmond

28035

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28047

GSK Investigational Site, Madrid

29201

GSK Investigational Site, Columbia

30513

GSK Investigational Site, Blue Ridge

32204

GSK Investigational Site, Jacksonville

32789

GSK Investigational Site, Winter Park

33136

GSK Investigational Site, Miami

35211

GSK Investigational Site, Birmingham

44340

GSK Investigational Site, Guadalajara

46201

GSK Investigational Site, Indianapolis

46520

GSK Investigational Site, Sagunto/Valencia

46601

GSK Investigational Site, South Bend

48073

GSK Investigational Site, Royal Oak

53792

GSK Investigational Site, Madison

55430

GSK Investigational Site, Brooklyn Center

60596

GSK Investigational Site, Frankfurt am Main

60612

GSK Investigational Site, Chicago

61615

GSK Investigational Site, Peoria

63141

GSK Investigational Site, St Louis

70458

GSK Investigational Site, Slidell

73485

GSK Investigational Site, Unterschneidheim

75230

GSK Investigational Site, Dallas

77027

GSK Investigational Site, Houston

77030

GSK Investigational Site, Houston

77074

GSK Investigational Site, Houston

77701

GSK Investigational Site, Beaumont

78126

GSK Investigational Site, Königsfeld im Schwarzwald

78207

GSK Investigational Site, San Antonio

78237

GSK Investigational Site, San Antonio

80209

GSK Investigational Site, Denver

80220

GSK Investigational Site, Denver

85282

GSK Investigational Site, Tempe

85567

GSK Investigational Site, Grafing

87106

GSK Investigational Site, Albuquerque

89014

GSK Investigational Site, Henderson

89103

GSK Investigational Site, Las Vegas

90806

GSK Investigational Site, Long Beach

91105

GSK Investigational Site, Pasadena

92108

GSK Investigational Site, San Diego

92128

GSK Investigational Site, San Diego

92691

GSK Investigational Site, Mission Viejo

92780

GSK Investigational Site, Tustin

92835

GSK Investigational Site, Fullerton

93105

GSK Investigational Site, Santa Barbara

94062

GSK Investigational Site, Redwood City

95482

GSK Investigational Site, Ukiah

97232

GSK Investigational Site, Portland

98026

GSK Investigational Site, Edmonds

99204

GSK Investigational Site, Spokane

99510

GSK Investigational Site, Apolda

7510605

GSK Investigational Site, Santiago

06050

GSK Investigational Site, New Britain

06850

GSK Investigational Site, Norwalk

02215

GSK Investigational Site, Boston

01199

GSK Investigational Site, Springfield

53209-0996

GSK Investigational Site, Milwaukee

A-1030

GSK Investigational Site, Vienna

A-1090

GSK Investigational Site, Vienna

A-1140

GSK Investigational Site, Vienna

V6Z 2K8

GSK Investigational Site, Vancouver

R3A 1R9

GSK Investigational Site, Winnipeg

P1B 2H3

GSK Investigational Site, North Bay

K1H 7W9

GSK Investigational Site, Ottawa

K9J 7B3

GSK Investigational Site, Peterborough

K7A 2H6

GSK Investigational Site, Smiths Falls

M5C 2T2

GSK Investigational Site, Toronto

H7T 2P5

GSK Investigational Site, Laval

H1T 2M4

GSK Investigational Site, Montreal

G1V 4G2

GSK Investigational Site, Sainte-Foy

Unknown

GSK Investigational Site, Viña del Mar

GSK Investigational Site, Santiago

GSK Investigational Site, Alicante

04552

GSK Investigational Site, Borna

04509

GSK Investigational Site, Delitzsch

01307

GSK Investigational Site, Dresden

02826

GSK Investigational Site, Görlitz

04107

GSK Investigational Site, Leipzig

LV 3001

GSK Investigational Site, Jelgava

LV 1006

GSK Investigational Site, Riga

LV1002

GSK Investigational Site, Riga

LV1079

GSK Investigational Site, Riga

LV 3201

GSK Investigational Site, Talsi

LV 4201

GSK Investigational Site, Valmiera

3818 ES

GSK Investigational Site, Amersfoort

2331 JE

GSK Investigational Site, Leiden

3021 HC

GSK Investigational Site, Rotterdam

1689 PZ

GSK Investigational Site, Zwaag

975 17

GSK Investigational Site, Banská Bystrica

813 69

GSK Investigational Site, Bratislava

036 59

GSK Investigational Site, Martin

L7 8XP

GSK Investigational Site, Liverpool

EH3 9YW

GSK Investigational Site, Edinburgh

PA2 9PN

GSK Investigational Site, Paisley

BA1 3NG

GSK Investigational Site, Bath

EH54 6PP

GSK Investigational Site, Livingston

NE9 6SX

GSK Investigational Site, Gateshead

PO30 5TG

GSK Investigational Site, Newport

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00500955 - Rosiglitazone on Microalbuminuria in Type 2 Diabetics | Biotech Hunter | Biotech Hunter